Asia-Pacific: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Asia-Pacific

The Asia-Pacific prophylactic medicaments containing insulin market expanded significantly to $X.4B in 2022, growing by X% against the previous year. Over the period under review, consumption enjoyed prominent growth. Over the period under review, the market attained the peak level at $X.6B in 2020; however, from 2021 to 2022, consumption remained at a lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Asia-Pacific

In value terms, prophylactic medicaments containing insulin production expanded notably to $X.8B in 2022 estimated in export price. Overall, production saw a resilient increase. The growth pace was the most rapid in 2013 when the production volume increased by X%. Over the period under review, production hit record highs at $X.7B in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in Asia-Pacific

In 2022, shipments abroad of medicaments containing insulin but not antibiotics in measured doses increased by X% to X tons, rising for the second consecutive year after seven years of decline. Overall, exports continue to indicate modest growth. The growth pace was the most rapid in 2013 when exports increased by X%. As a result, the exports reached the peak of X tons. From 2014 to 2022, the growth of the exports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin exports contracted to $X in 2022. In general, exports posted a significant expansion. The most prominent rate of growth was recorded in 2021 when exports increased by X% against the previous year. As a result, the exports reached the peak of $X, and then dropped in the following year.

Exports by Country

India (X tons), China (X tons) and Malaysia (X tons) represented roughly X% of total exports in 2022. Singapore (X tons) followed a long way behind the leaders.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the leading exporting countries, was attained by Singapore (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, China ($X) remains the largest prophylactic medicaments containing insulin supplier in Asia-Pacific, comprising X% of total exports. The second position in the ranking was taken by India ($X), with a X% share of total exports. It was followed by Malaysia, with an X% share.

In China, prophylactic medicaments containing insulin exports increased at an average annual rate of X% over the period from 2012-2022. In the other countries, the average annual rates were as follows: India (X% per year) and Malaysia (X% per year).

Export Prices by Country

The export price in Asia-Pacific stood at $X per ton in 2022, declining by X% against the previous year. Overall, the export price, however, continues to indicate a significant increase. The growth pace was the most rapid in 2015 an increase of X% against the previous year. Over the period under review, the export prices hit record highs at $X per ton in 2021, and then shrank sharply in the following year.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was China ($X per ton), while India ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Malaysia (X%), while the other leaders experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in Asia-Pacific

In 2022, purchases abroad of medicaments containing insulin but not antibiotics in measured doses decreased by X% to X tons, falling for the second consecutive year after three years of growth. The total import volume increased at an average annual rate of X% from 2012 to 2022; however, the trend pattern indicated some noticeable fluctuations being recorded in certain years. The pace of growth appeared the most rapid in 2013 when imports increased by X%. The volume of import peaked at X tons in 2020; however, from 2021 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports fell markedly to $X in 2022. In general, imports continue to indicate a slight downturn. The pace of growth was the most pronounced in 2016 when imports increased by X% against the previous year. The level of import peaked at $X in 2021, and then declined significantly in the following year.

Imports by Country

Japan (X tons), China (X tons), Pakistan (X tons), South Korea (X tons), Australia (X tons), Taiwan (Chinese) (X tons), Indonesia (X tons), India (X tons), Vietnam (X tons), Thailand (X tons), the Philippines (X tons) and Malaysia (X tons) represented roughly X% of total imports in 2022.

From 2012 to 2022, the biggest increases were recorded for Malaysia (with a CAGR of X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin importing markets in Asia-Pacific were Japan ($X), China ($X) and India ($X), together comprising X% of total imports. Australia, South Korea, Taiwan (Chinese), Pakistan, Indonesia, Vietnam, the Philippines, Thailand and Malaysia lagged somewhat behind, together comprising a further X%.

Among the main importing countries, Malaysia, with a CAGR of X%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Asia-Pacific stood at $X per ton in 2022, shrinking by X% against the previous year. In general, the import price saw a noticeable descent. The most prominent rate of growth was recorded in 2021 when the import price increased by X%. Over the period under review, import prices attained the peak figure at $X per ton in 2012; however, from 2013 to 2022, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was India ($X per ton), while Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Pakistan (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :